Genetic variation on 9p22 is associated with abnormal ovarian ultrasound results in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.
A recent ovarian cancer genome-wide association study (GWAS) identified a locus on 9p22 associated with reduced ovarian cancer risk. The single nucleotide polymorphism (SNP) markers localize to the BNC2 gene, which has been associated with ovarian development.We analyzed the association of 9p22 SNPs...
Main Authors: | Nicolas Wentzensen, Amanda Black, Kevin Jacobs, Hannah P Yang, Christine D Berg, Neil Caporaso, Ulrike Peters, Lawrence Ragard, Saundra S Buys, Stephen Chanock, Patricia Hartge |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2011-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3131287?pdf=render |
Similar Items
-
Breast cancer epidemiology according to recognized breast cancer risk factors in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial Cohort
by: Leitzmann Michael F, et al.
Published: (2009-03-01) -
<it>SLC6A3 </it>and body mass index in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial
by: Hayes Richard B, et al.
Published: (2009-01-01) -
Potential excess mortality in BRCA1/2 mutation carriers beyond breast, ovarian, prostate, and pancreatic cancers, and melanoma.
by: Phuong L Mai, et al.
Published: (2009-01-01) -
CLINICAL SIGNIFICANCE OF BIOMARKERS IN OVARIAN CANCER, PROSTATE CANCER, COLORECTAL CANCER
by: N. V. Marshutina, et al.
Published: (2016-03-01) -
Dairy consumption and risk of esophagus cancer in the prostate, lung, colorectal, and ovarian cohort
by: Tingting Wang, et al.
Published: (2022-12-01)